Anzeige
Mehr »
Freitag, 25.07.2025 - Börsentäglich über 12.000 News
Lizenz aktiviert - Kooperation fix: Diese Aktie will jetzt den Milliardenmarkt erobern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
258 Leser
Artikel bewerten:
(1)

BCC Research LLC: Biophotonics: Strategic Market and Tech Overview

"A strategic overview of biophotonics innovations, market trends, and cross-industry applications shaping the future of healthcare and life sciences."

BOSTON, July 23, 2025 /PRNewswire/ -- According to the latest study from BCC Research, "Biophotonics: Technologies and Global Markets" was valued at $62.6 billion in 2024 and it is expected to grow from $68.4 billion in 2025 to reach $113.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% from 2025 to 2030.

BCC Research (PRNewsfoto/BCC Research LLC)

The report offers a comprehensive look at the biophotonics market, examining its growth across applications like imaging, sensing, and light-based therapies. It analyzes usage trends in medical diagnostics, therapeutics, and testing, as well as regional dynamics across North America, Europe, Asia-Pacific, and other global markets. Market drivers, challenges, and innovations in material design are discussed, along with insights into leading companies and their offerings.

This report is particularly relevant today as the biophotonics market is undergoing rapid transformation driven by technological advances and increased demand for healthcare. Innovations in optical technologies are expanding the scope of biophotonics across multiple industries, particularly in non-invasive diagnostics and therapeutic applications. The rising prevalence of chronic diseases further fuels the need for advanced, precise, and less intrusive medical solutions. In this dynamic environment, staying informed about market trends and emerging opportunities is crucial for stakeholders aiming to leverage the full potential of biophotonics.

The factors driving the market's growth include:

Growing Prevalence of Chronic Diseases: The increasing global burden of chronic illnesses like cancer, diabetes, and cardiovascular diseases is driving demand for advanced diagnostic and therapeutic tools. Biophotonics offers precise, real-time imaging and monitoring solutions that support early detection and effective treatment, making it essential in modern healthcare.

Rising Demand for Non-Invasive Diagnostics: Patients and clinicians prefer non-invasive diagnostic methods for their safety, comfort, and efficiency. Biophotonics technologies such as optical coherence tomography and Raman spectroscopy enable accurate, painless diagnostics, reducing the need for surgical procedures and improving patient outcomes.

Advances in Optical Technologies: Rapid innovation in lasers, fiber optics, and imaging systems has enhanced the performance and accessibility of biophotonics tools. These advances allow for higher resolution, faster data processing, and integration with AI, expanding their use in both clinical and research settings.

Expansion into Non-Medical Applications: Biophotonics is finding applications in industries like agriculture, food safety, environmental monitoring, and forensics. Its ability to detect biological and chemical changes makes it valuable for quality control, pollution detection, and security, broadening its market reach.

Increasing Penetration of Personalized Medicine and Precision Healthcare: As healthcare moves toward personalized and precision approaches, biophotonics plays a key role by enabling molecular-level diagnostics and targeted therapies. Its capabilities support tailored treatment plans based on individual patient profiles, aligning with the future of medicine.

Request a sample copy of the global market for biophotonics report.

Report Synopsis

Report Metric

Details

Base year considered

2024

Forecast period considered

2025-2030

Base year market size

$62.6 billion

Market size forecast

$113.1 billion

Growth rate

CAGR of 10.6% from 2025 to 2030

Segments covered

Application, Technique, End Use and Region

Regions covered

North America, Europe, Asia-Pacific and the Rest of the World (Latin America and the Middle East and Africa)

Countries covered

U.S., Canada, Germany, U.K., France, Japan, China and India

Market drivers







  • Growing prevalence of chronic diseases.
  • Rising demand for non-invasive diagnostics.
  • Advances in optical technologies.
  • Expansion into non-medical applications.
  • Increasing penetration of personalized medicine and precision healthcare.

Interesting facts:

  • In vitro biophotonics accounted for 72% of the biophotonics market in 2024 because of the rising need for early disease detection, better optical imaging technologies, and increased use of personalized medicine.
  • North America accounted for 52.8% of the biophotonics market in 2024 thanks to its strong technical infrastructure, sizable investments in research, and demand from healthcare, life sciences, and biotech industries. Growth was also boosted by partnerships and innovations from leading companies Thermo Fisher Scientific, Danaher Corp., and Hamamatsu Photonics.
  • Combining biophotonics with nanotechnology has led to major improvements in ultra-sensitive diagnostic tools and targeted treatments. This has made disease diagnosis more accurate and helped create personalized treatment plans that improve patient outcomes.

Emerging startups

  • Lithium Lasers
  • DYSIS Medical Inc.
  • Sascan Meditech Pvt Ltd

The report addresses the following questions:

  1. What is the projected size and growth rate of the market?

    - The market is projected to reach $113.1 billion by the end of 2030, growing at a CAGR of 10.6% during the forecast period.

  2. Which factors are driving the growth of the market?

    - The key factors driving the market include the growing prevalence of chronic diseases, rising demand for non-invasive diagnostics, and advances in optical technologies.

  3. Which market segments are covered in the report?

    - The four market segments covered are application, technique, end use and region.

  4. Which end-use segment will be dominant through 2030?

    - The medical diagnostics end-use segment is expected to dominate the market through 2030, driven by the increasing demand for non-invasive and real-time diagnostic techniques, advancements in optical imaging technologies, and the rising prevalence of chronic diseases such as cancer and cardiovascular disorders.

  5. Which region has the largest market share?

    - North America holds the largest share of the global market, due to its advanced technical infrastructure, sizable R&D investments, and demand from sectors such as healthcare, life sciences, and biotech.

Market leaders include:

  • BECTON DICKINSON
  • BIOPHOTONICS DIAGNOSTICS GMBH
  • EXCELITAS TECHNOLOGIES CORP.
  • GLENBROOK TECHNOLOGIES
  • HAMAMATSU PHOTONICS K.K.
  • IDEX
  • IPG PHOTONICS CORP.
  • ISMO BIOPHOTONICS PVT. LTD.
  • LUMA BIOPHOTONICS
  • OLYMPUS CORP.
  • OXFORD INSTRUMENTS
  • OZ OPTICS LTD.
  • THERMO FISHER SCIENTIFIC INC.
  • TOPTICA PHOTONICS AG
  • ZEISS

Related reports:

Photonic Integrated Circuits: Global Markets with Special Focus on Silicon Photonics: The report offers a comprehensive overview of the photonic integrated circuits (PICs) market, examining key components such as transceivers, lasers, modulators, detectors, MUX/DEMUX, and optical amplifiers. It highlights their application across sectors like optical communication, sensing, biophotonics, and signal processing. The study provides regional insights spanning North America, Europe, Asia-Pacific, and the Rest of the World, while analyzing market dynamics, including drivers, challenges, and emerging trends. It also emphasizes advances in material design and performance and concludes with analysis of the competitive landscape.

Medical Imaging: A BCC Research Outlook: The report offers a detailed analysis of the medical imaging market, covering key product types such as X-ray, ultrasound, MRI, CT, nuclear imaging, and emerging modalities like optical and photoacoustic imaging. It provides sales forecasts segmented by product, application, and end user, while examining regional dynamics, market drivers, and the competitive landscape. The study also highlights technological innovations shaping the future of medical imaging.

Purchase a copy of the report direct from BCC Research.

For further information on any of these reports or to make a purchase, contact info@bccresearch.com.

About BCC Research

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

Contact Us

Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA
Email: info@bccresearch.com
Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/5428508/BCC_Research_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/biophotonics-strategic-market-and-tech-overview-302512258.html

© 2025 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.